Clinical Trials
Intracranial Pressure Reduced Through Injectable Peptide
It has come to light that patient with idiopathic intracranial hypertension- IIH can be treated with an injectable peptide used for type 2 diabetes. This has been found in a Phase II trial. As per the study’s latest findings,...
Clinical Trials
Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide
Greenphire, the global leader in financial lifecycle management for clinical trials, today announced an expansion of its agreement with Merck, known as MSD outside the United States and Canada. This expanded agreement now includes the use of Greenphire's ClinCard...
Clinical Trials
Shuttle Pharmaceuticals Engages UI Pharmaceuticals for Formulation and Clinical Batch Manufacture of Ropidoxuridine for Brain Tumor Clinical Trial
Shuttle Pharmaceuticals Holdings, Inc., a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has signed an agreement with the University of Iowa (UI) Pharmaceuticals...
Clinical Trials
LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
LEO Pharma, a global leader in medical dermatology, and ICON plc announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition...
Clinical Trials
Clinical Trial Registration Enhanced By Default Eligibility
A new approach that has been created at the Medical University of South Carolina that specifically aims at enhancing clinical trial eligibility has shown positive results.
The patient outreach recruitment team that has been floated by the South Carolina Clinical...
Clinical Trials
Response To The Chemotherapy of Tumour Cells Incidental
A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is their ability to respond randomly to chemotherapy.
Understanding why some tumour cells develop resistance to chemotherapy...
Clinical Trials
TB Vaccine Which Is Temperature Stable Gives Immune Response
ID93+GLA-SE, a freeze-dried tuberculosis vaccine, was confirmed to be safe in the first clinical study of any subunit TB vaccine in a temperature-stable form.
The effectiveness of a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read